JP2026016690A5 - - Google Patents
Info
- Publication number
- JP2026016690A5 JP2026016690A5 JP2025184422A JP2025184422A JP2026016690A5 JP 2026016690 A5 JP2026016690 A5 JP 2026016690A5 JP 2025184422 A JP2025184422 A JP 2025184422A JP 2025184422 A JP2025184422 A JP 2025184422A JP 2026016690 A5 JP2026016690 A5 JP 2026016690A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- rifabutin
- max
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962899257P | 2019-09-12 | 2019-09-12 | |
| US62/899,257 | 2019-09-12 | ||
| US201962902019P | 2019-09-18 | 2019-09-18 | |
| US62/902,019 | 2019-09-18 | ||
| US201962941160P | 2019-11-27 | 2019-11-27 | |
| US62/941,160 | 2019-11-27 | ||
| US202062977659P | 2020-02-17 | 2020-02-17 | |
| US62/977,659 | 2020-02-17 | ||
| PCT/IB2020/000647 WO2021048611A1 (en) | 2019-09-12 | 2020-08-03 | Rifabutin treatment methods, uses, and compositions |
| JP2022516161A JP7769605B2 (ja) | 2019-09-12 | 2020-08-03 | リファブチン処置法、使用および組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516161A Division JP7769605B2 (ja) | 2019-09-12 | 2020-08-03 | リファブチン処置法、使用および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026016690A JP2026016690A (ja) | 2026-02-03 |
| JP2026016690A5 true JP2026016690A5 (enExample) | 2026-05-18 |
Family
ID=72432957
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516161A Active JP7769605B2 (ja) | 2019-09-12 | 2020-08-03 | リファブチン処置法、使用および組成物 |
| JP2022516163A Active JP7804570B2 (ja) | 2019-09-12 | 2020-08-03 | 抗生物質併用療法 |
| JP2025145104A Pending JP2025176113A (ja) | 2019-09-12 | 2025-09-02 | 抗生物質併用療法 |
| JP2025184422A Pending JP2026016690A (ja) | 2019-09-12 | 2025-10-31 | リファブチン処置法、使用および組成物 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516161A Active JP7769605B2 (ja) | 2019-09-12 | 2020-08-03 | リファブチン処置法、使用および組成物 |
| JP2022516163A Active JP7804570B2 (ja) | 2019-09-12 | 2020-08-03 | 抗生物質併用療法 |
| JP2025145104A Pending JP2025176113A (ja) | 2019-09-12 | 2025-09-02 | 抗生物質併用療法 |
Country Status (17)
| Country | Link |
|---|---|
| US (6) | US11207305B2 (enExample) |
| EP (3) | EP4420673A3 (enExample) |
| JP (4) | JP7769605B2 (enExample) |
| KR (1) | KR20220103698A (enExample) |
| CN (3) | CN120860031A (enExample) |
| AU (2) | AU2020344214B2 (enExample) |
| BR (2) | BR112022004645A2 (enExample) |
| CA (2) | CA3154129A1 (enExample) |
| ES (1) | ES2982067T3 (enExample) |
| HR (1) | HRP20240818T1 (enExample) |
| HU (1) | HUE066936T2 (enExample) |
| MX (1) | MX2022003077A (enExample) |
| PH (1) | PH12022550610A1 (enExample) |
| PL (1) | PL4028001T3 (enExample) |
| RS (1) | RS65681B1 (enExample) |
| SM (1) | SMT202400250T1 (enExample) |
| WO (2) | WO2021048611A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230364065A1 (en) | 2022-05-16 | 2023-11-16 | BioVersys AG | Antibiotic combination therapies |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645508B1 (en) * | 1999-06-18 | 2003-11-11 | Jivn-Ren Chen | Stable L-ascorbic acid composition |
| CN101362067A (zh) * | 2007-08-06 | 2009-02-11 | 天津科技大学 | 一种微胶囊制备方法 |
| CA2714043C (en) * | 2008-02-08 | 2016-11-08 | Giaconda Limited | Methods and compositions for treating inflammatory bowel disease |
| MY158809A (en) | 2010-09-22 | 2016-11-15 | Craun Res Sdn Bhd | Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
| EA016410B1 (ru) | 2010-11-13 | 2012-04-30 | Ооо "Нпк Наносистема" | Фармацевтическая композиция на основе наночастиц циклодекстрина, содержащих рифабутин, способ ее получения, способ лечения микобактериоза и геликобактерной инфекции (варианты) |
| EP2670417A4 (en) * | 2011-01-31 | 2014-07-09 | Us Army | METHOD AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS WITH IRON RADIATORS |
| CN102178604B (zh) | 2011-03-22 | 2014-03-05 | 中国人民解放军第三0九医院 | 凝胶微球制备装置、方法及可注射抗结核药物凝胶微球 |
| RU2472512C1 (ru) * | 2011-12-06 | 2013-01-20 | Общество С Ограниченной Ответственностью "Ибмх-Экобиофарм" | Противотуберкулезная композиция и способ ее получения |
| WO2016013986A1 (en) * | 2014-07-25 | 2016-01-28 | Agency For Science, Technology And Research | Antibiotic compositions for treating bacterial infections |
| HK1243740A1 (zh) * | 2014-09-04 | 2018-07-20 | Labrador Diagnostics Llc | 病原体和抗微生物剂抗性检测 |
| US9763996B2 (en) | 2015-01-16 | 2017-09-19 | Northern Antibiotics, Ltd. | Polymyxin derivative and uses thereof |
| WO2016178240A1 (en) * | 2015-05-04 | 2016-11-10 | Gufic Biosciences Limited | A freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof |
| JP7072898B2 (ja) * | 2016-08-16 | 2022-05-23 | ユニバーシティ オブ ロチェスター | ポリミキシンｂ／トリメトプリム系の治療薬を含有する医薬組成物 |
| AU2018219149A1 (en) * | 2017-02-07 | 2019-09-19 | Unm Rainforest Innovations | Isotope enhanced ambroxol for long lasting autophagy induction |
| US11701346B2 (en) * | 2018-11-28 | 2023-07-18 | University Of Southern California | Rifabutin for the treatment of acinetobacter baumannii |
-
2020
- 2020-08-03 EP EP24169078.3A patent/EP4420673A3/en active Pending
- 2020-08-03 HU HUE20768692A patent/HUE066936T2/hu unknown
- 2020-08-03 US US16/983,718 patent/US11207305B2/en active Active
- 2020-08-03 SM SM20240250T patent/SMT202400250T1/it unknown
- 2020-08-03 KR KR1020227012086A patent/KR20220103698A/ko active Pending
- 2020-08-03 AU AU2020344214A patent/AU2020344214B2/en active Active
- 2020-08-03 MX MX2022003077A patent/MX2022003077A/es unknown
- 2020-08-03 CN CN202511016208.7A patent/CN120860031A/zh active Pending
- 2020-08-03 EP EP20768691.6A patent/EP4028000A1/en active Pending
- 2020-08-03 BR BR112022004645A patent/BR112022004645A2/pt unknown
- 2020-08-03 WO PCT/IB2020/000647 patent/WO2021048611A1/en not_active Ceased
- 2020-08-03 CN CN202080077348.4A patent/CN114980889A/zh active Pending
- 2020-08-03 BR BR112022004672A patent/BR112022004672A2/pt unknown
- 2020-08-03 PL PL20768692.4T patent/PL4028001T3/pl unknown
- 2020-08-03 AU AU2020347536A patent/AU2020347536B2/en active Active
- 2020-08-03 CA CA3154129A patent/CA3154129A1/en active Pending
- 2020-08-03 HR HRP20240818TT patent/HRP20240818T1/hr unknown
- 2020-08-03 RS RS20240688A patent/RS65681B1/sr unknown
- 2020-08-03 PH PH1/2022/550610A patent/PH12022550610A1/en unknown
- 2020-08-03 EP EP20768692.4A patent/EP4028001B1/en active Active
- 2020-08-03 JP JP2022516161A patent/JP7769605B2/ja active Active
- 2020-08-03 ES ES20768692T patent/ES2982067T3/es active Active
- 2020-08-03 CA CA3154317A patent/CA3154317A1/en active Pending
- 2020-08-03 JP JP2022516163A patent/JP7804570B2/ja active Active
- 2020-08-03 US US16/983,689 patent/US11351158B2/en active Active
- 2020-08-03 CN CN202080077930.0A patent/CN115052597B/zh active Active
- 2020-08-03 WO PCT/IB2020/000645 patent/WO2021048610A1/en not_active Ceased
-
2021
- 2021-12-27 US US17/562,496 patent/US11766425B2/en active Active
-
2022
- 2022-06-06 US US17/833,326 patent/US11833139B2/en active Active
-
2023
- 2023-10-20 US US18/491,243 patent/US12257241B2/en active Active
-
2025
- 2025-03-24 US US19/088,662 patent/US20250281469A1/en active Pending
- 2025-09-02 JP JP2025145104A patent/JP2025176113A/ja active Pending
- 2025-10-31 JP JP2025184422A patent/JP2026016690A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20110263606A1 (en) | Solid oral dosage forms comprising tadalafil | |
| JP2002534382A (ja) | タキサン類の薬学的調合物 | |
| CZ20033241A3 (cs) | Kůži prostupující přípravek obsahující selektivně inhibující cyklooxygenázu@@ a jednosytný alkohol | |
| JPH0729939B2 (ja) | 全身性薬物を局所投与するための透過促進剤 | |
| CN102014925A (zh) | 氟维司群配制剂 | |
| US20050239747A1 (en) | Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods | |
| CN101854913A (zh) | 含有缬沙坦的液体组合物 | |
| JP2005539003A (ja) | 経口投与用シクロスポリン含有医薬組成物 | |
| RU2011104205A (ru) | Такролимус для улучшенного лечения пациентов с трансплантатами | |
| JP2022173567A (ja) | 注腸剤 | |
| JPH10158169A (ja) | 塩化トロスピウムを含んだ医薬製剤、その調整方法および使用方法 | |
| JP2026027477A5 (enExample) | ||
| ITRM960396A1 (it) | Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali. | |
| CN101756954A (zh) | 硝酸异山梨酯的鼻粘膜给药制剂及其制备方法 | |
| US20170105970A1 (en) | Ondansetron sublingual spray formulation | |
| JP2018108993A (ja) | 注腸剤 | |
| WO2024063712A1 (en) | Pharmaceutical compositions comprising azelastine hci, fluticasone propionate and relevant excipients | |
| HRP20240818T1 (hr) | Metode liječenja rifabutinom, upotreba i sastavi | |
| CN113768902A (zh) | 一种左西孟坦的制备方法 | |
| CA3225946A1 (en) | Aqueous bumetanide-containing liquid | |
| CN111700882A (zh) | 细辛脑舌下给药系统 | |
| CN100413501C (zh) | 白头翁素透皮吸收贴片 | |
| RU2024117395A (ru) | Композиции и способы для лечения covid-19 | |
| CN100370982C (zh) | 白头翁素透皮凝胶剂 | |
| JP2026500440A (ja) | 優れた薬物動態特性を有するフルベストラントの医薬組成物及びその製造方法 |